Pulmonary biomarkers based on alterations in protein expression after exposure to arsenic

Environmental Health Perspectives

Volumn 115, Issue 4, 2007, Pages 586-591

  Lantz, R Clark ^a   Lynch, Brandon J ^a   Boitano, Scott ^a,b,c   Poplin, Gerald S ^a   Littau, Sally ^a   Tsaprailis, George ^a   Burgess, Jefferey L ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Arsenic; Human; Lavage; Lung; Mice; Proteomics; Sputum

Indexed keywords

ADVANCED GLYCATION END PRODUCT; APOLIPOPROTEIN A1; ARSENIC; BIOLOGICAL MARKER; DRINKING WATER; ENOLASE; GLUTATHIONE TRANSFERASE; PEROXIREDOXIN;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; REGRESSION ANALYSIS; SPUTUM ANALYSIS; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

ANIMALS; ARSENIC; BIOLOGICAL MARKERS; DISEASE MODELS, ANIMAL; ENVIRONMENTAL POLLUTANTS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MASS SPECTROMETRY; MICE; PROTEINS; PROTEOMICS; REFERENCE VALUES; SPUTUM; WATER SUPPLY;

ANIMALIA; MUS;

EID: 34247174019     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9611     Document Type: Article

References (40)

1. Andon NL, Hollingworth S, Koller A, Greenland AJ, Yates JR III, Hanes PA. 2002. Proteomic characterization of wheat amyloplasts using identification of proteins by tandem mass spectrometry. Proteomics 2:1156-1168.
2. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, et al. 2005. Understanding RAGE, the receptor for advanced glycation end products. J Mol Med 83:876-886.
3. Burgess JL, Nanson CJ, Gerkin R, Witten ML, Hysong TA, Lantz RC. 2002. Rapid decline in sputum IL-10 concentration following occupational smoke exposure. Inhal Toxicol 14:133-140.
4. Chen GS, Gharib DG, Thomas DG, Huang CC, Misek DE, Kuick RD, et al. 2003. Proteomic analysis of elF-5A in lung adenocarcinoma. Proteomics 3:496-504.
5. Chen H, Liu J, Merrick BA, Waalkes MP. 2001. Genetic events associated with arsenic-induced malignant transformation: applications of cDNA microarray technology. Mol Carcinog 30:79-87.
6. Chiou HY, Hsueh YM, Liaw KF, Horng SF, Chiang MH, Pu YS, et al. 1995. Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res 55:1296-1300.
7. Chiou JM, Wang SL, Chen CJ, Deng CR, Lin W, Tai TY. 2005, Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int J Epidemiol 34:936-943.
8. Craig R, Cortens JP, Beavis RC. 2004. Open sources system for analyzing, validating, and storing protein identification data. J Proteome Res 3:1234-1242.
9. Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, Cuccia M, et al. 2005. Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 25:1032-1037.
10. Gong Z, Lu X, Cullen WR, Le XC. 2001. Unstable trivalent arsenic metabolites, monomethylarsonous acid and dimethylarsinous acid. J Anal At Spectrom 6:1409-1413.
11. Goova MT, Li J, Kislinger T, Gu W, Lu Y, Bucciarelli LG, et al. 2001. Blockade of receptor for advanced glycation end-products restores effective wound healing in diabetic mice. Am J Pathol 159:513-525.
12. Hadi AS. 1992. Identifying multiple outliers in multivariate data. J R Stat Soc Series B 54:761-771.
13. Hanford LE, Enghild JJ, Valnickova Z, Petersen SV, Schaefer LM, Schaefer TM, et al. 2004. Purification and characterization of mouse soluble receptor for advanced glycation end products (sRAGE). J Biol Chem 279:50019-50024.
14. He C, Yip TT, Chiu JF. 2003. Proteomic analyses of arsenic-induced cell transformation with SELDI-TOF ProteinChip technology. J Cell Biochem 88:1-8.
15. Hofmann HS, Hansen G, Burdach S, Bartling B, Silber RE, Simm A. 2004. Discrimination of human lung neoplasm from normal lung by two target genes. Am J Respir Crit Care Med 170:516-519.
16. Hunter TC, Andon NL, Koller A, Yates JR, Haynes PA. 2002. The functional proteomics toolbox: methods and applications. J Chromatogr B AnalytTechnol Biomed Life Sci 782:165-181.
17. International Agency for Research on Cancer. 1987. Arsenic. IARC Monogr Eval Carcinog Risk Hum Suppl 7:100-106.
18. Josyula AB, Poplin S, Kurzius-Spencer M, McClellen H, Kopplin M, Sturup S, et al. 2006. Environmental arsenic exposure and sputum metalloproteinase concentrations. Environ Res 102:283-290.
19. Kim HS, Manevich Y, Feinstein SI, Pak JH, Ho YS, Fisher AB. 2003. Induction of 1-cys paroxiredoxin expression by oxidative stress in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 285:L363-L369.
20. Lau ATY, He GY, Chiu, JF. 2004. A proteome analysis of the arsenite response in cultured lung cells: evidence for in vitro oxidative stress-induced apoptosis. Biochem J 382:641-650.
21. Li J, Schmidt AM. 1997. Characterization and functional analysis of the promoter of RAGE, the receptor for advanced glycation end products. J Biol Chem 272:16498-16506.
22. Lu T, Lie J, LeCluyse EL, Zhou YS, Cheng ML, Waalkes MP. 2001. Application of cDNA microarray to the study of arsenic-induced liver disease in the population of Guishou, China. Toxicol Sci 59:185-192.
23. Moser B, Hudson BI, Schmidt AM. 2005. Soluble RAGE: a hot new biomarker for the hot joint? Arthritis Res Ther 7:142-144.
24. Navas-Acien A, Silbergeld EK, Streeter RA, Clark JM, Burke TA, Guallar E. 2006. Arsenic exposure and type 2 diabetes: a systematic review of the experimental and epidemiologic evidence. Environ Health Perspect 114:641-648.
25. NCBI (National Center for Biotechnology Information). 2005. Protein Sequence Database. Available: http://www.ncbi.nim.nih.gov/entrez/ query.fcgi?db=Protein [accessed 14 July 2005].
26. NRC (National Research Council). 1997. Building a Foundation for Sound Environmental Decisions, Washington, DC:National Academy Press.
27. Pullerits R, Bokarewa M, Dahlberg L, Tarkowski A. 2005. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control. Arthritis Res Ther 7:R817-824.
28. Ramasamy R, Yan SF, Schmidt AM. 2005. The RAGE axis and endothelial dysfunction: maladaptive roles in the diabetic vasculature and beyond. Trends Cardiovasc Med 15:237-243.
29. Rossman TG. 2003. Mechanism of arsenic carcinogenesis: an integrated approach. Mutat Res 533:37-65.
30. Rutters H, Zurbig P, Halter R, Borlak J. 2006. Towards a lung adenocarcinoma proteome map: studies with SP-C/c-raf transgenic mice. Proteomics 6:3127-3137.
31. Shirasawa M, Fujiwara N, Hirabayashi S, Ohno H, Iida J, Makita K, et al. 2004. Receptor for advanced glycation end-products is a marker of type I lung alveolar cells. Genes Cells 9:165-174.
32. Smith AH, Marshall G, Yuan Y, Ferreccio C, Liaw J, von Ehrenstein O, et al. 2006. Increased mortality from lung cancer and bronchiectasis in young adults after exposure to arsenic in utero and in early childhood. Environ Health Perspect 114:1293-1296.
33. Tabb OL, McDonald WH, Yates JR III. 2003. DTASelect and contrast: tools for assembling and comparing protein identification from shotgun proteomics. J Proteome Res 1:21-26.
34. Tanaka M, Maeda K, Nakashima K. 1995. Chicken alpha-enolase but not beta-enolase has a Src-dependent tyrosine-phosphorylation site: cDNA cloning and nucleotide sequence analysis. J Biochem 117:554-559.
35. Tohgi H, Utsugisawa K, Nagane Y, Yoshimurs M, Ukitsu M, Genda Y. 1999. Decrease with age in methylcytosines in the promoter region of receptor for advanced glycated end products (RAGE) gene in autopsy human cortex. Brain Res Mol Brain Res 65:124-128.
36. Wattiez R, Falmagne P. 2005. Proteomics of bronchoalveolar lavage fluid. J Chromatogr 815:169-178.
37. Wattiez R, Noel-Georis I, Cruyt C, Broeckaert F, Bernard A, Falmagne P. 2003. Susceptibility to oxidative stress: proteomics analysis of bronchoalveolar lavage from ozone-sensitive and ozone-resistant strains of mice. Proteomics 3:658-665.
38. Wolters DA, Washburn MP, Yates JR III. 2001. An automated multidimensional protein identification technology for shotgun proteomics. Anal Chem 73:5683-5690.
39. Wu MM, Kuo TL, Hwang YH, Chen CJ. 1989, Dose-response relation between arsenic concentration in well water and mortality from cancers and vascular disease. Am J Epidemiol 130:1123-1132.
40. Zakharyan RA, Sampayo-Reyes A, Healy SM, Tsaprailis G, Board PG, Liebler DC, et al. 2001. Human monomethylarsonic acid (MMA(V)) reductase is a member of the glutathione-S-transferase superfamily. Chem Res Toxicol 14:1051-1057.